New COVID vaccine enters human testing phase
NCT ID NCT04839146
Summary
This early-stage study tested a new COVID-19 vaccine called ABNCoV2 in 45 healthy adults who hadn't had COVID-19 before. Researchers wanted to check if the vaccine was safe and how well it triggered an immune response. They tested different doses and formulations to find the best balance between effectiveness and side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARS COV 2 INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Radboud univserity medical center
Nijmegen, Gelderland, 6525GA, Netherlands
Conditions
Explore the condition pages connected to this study.